Sponsor hub

University of British Columbia clinical trial failures

Review 27 stopped clinical trials from University of British Columbia, including disease areas, phases, and classified stop reasons.

This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 4 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.

Total stopped trials27
Likely biological signals4
Shown below27

Dominant stop reasons

OPERATIONAL
14
OTHER/UNKNOWN
9
EFFICACY/FUTILITY
3
SAFETY
1

Notable sponsors

University of British Columbia
27

Related phases

Phase II
9
Phase IV
7
Unknown
4
Phase I
3
Phase III
3

Crawlable stopped-trial records

Open Explore

Showing up to 27 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.

NCT04955470: Ketamine Infusion for Rapid Reduction of Suicidality in Pediatrics

Phase I Suicidal Ideation trial by University of British Columbia. Stop reason: OPERATIONAL.

There were challenges with recruitment in the ED due to ED staffing shortages and we were unable to meet the expected recruitment rate. The decision to stop study recruitment was solely due to operational and logistical limitations.

NCT04944173: SCION: SABR and Checkpoint Inhibition of NSCLC

Phase II Non Small Cell Lung Cancer trial by University of British Columbia. Stop reason: EFFICACY/FUTILITY.

Overestimated pool of eligible patients and the potential participants either declined participation or did not meet eligibility criteria.